Lemborexant (Dayvigo)

lemborexant · Eisai

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lemborexant (Dayvigo), covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Lemborexant in Delayed Sleep Phase Syndrome [Phase 4]